English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Apr 26, 2023

U.S. Food and Drug Administration Issues Complete Response Letter for Mirikizumab

Patient Daily | Apr 26, 2023

RELIAS AND 321 COFFEE PARTNER TO OPEN INCLUSIVE CAFÉ AT RELIAS HEADQUARTERS

Patient Daily | Apr 26, 2023

Introducing Navina Mini – a Small Solution for Instant Results

Patient Daily | Apr 26, 2023

InterVenn Biosciences to Present Clinical Data on Circulating Serum Glycoproteins for Unprecedented Pre-Cancer Detection as “Poster of Distinction” at Digestive Disease Week 2023

Patient Daily | Apr 26, 2023

Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting

Patient Daily | Apr 26, 2023

Sotera Health Announces First-Quarter 2023 Earnings Release Date

Patient Daily | Apr 24, 2023

H1.co Named 2023 Website of the Year by the Health and IT Marketing Community

Patient Daily | Apr 24, 2023

The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology

Trending

+ Community
Patient Daily | Apr 28, 2025

ENT Practice Expert: AOCOO-HNS Clinical Assembly will feature 'at least four sessions that seem particularly valuable for physicians'

+ Pharmaceuticals
Patient Daily | Apr 28, 2025

Alliance Pharmacy CEO on FDA compounded tirzepatide block: The data used is not 'enough to say the shortage is really over'

+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Eli Lilly boosts federal lobbying spend as it ups legal pressure on compound pharmacies

+ Pharmaceuticals
Patient Daily | Apr 23, 2025

Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'

  • « First
  • «
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily